ZANIDATAMAB - Food and Drug Administration

Set ID
f2c3e67f-5518-4f2b-a6f6-2bbd4cb0c983
Type
Indexing - product concept
Effective date
2025-07-22
Version
1
Source
DailyMed source

Mapped DailyMed Labels#

Label, Relation, Manufacturer table
LabelRelationManufacturerEffective
These highlights do not include all the information needed to use ZIIHERA safely and effectively. See full prescribing information for ZIIHERA. ZIIHERA ® (zanidatamab‑hrii) for injection, for intravenous use Initial U.S. Approval: 2024Product nameJazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | WuXi Biologics Co., Ltd. | Almac Pharma Services LLC2026-08-24
These highlights do not include all the information needed to use ZIIHERA safely and effectively. See full prescribing information for ZIIHERA. ZIIHERA ® (zanidatamab‑hrii) for injection, for intravenous use. Initial U.S. Approval: 2024Product nameJazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals Ireland Limited | WuXi Biologics Co., Ltd. | Almac Pharma Services LLC2025-07-01